Description
ZSTK474 is an inhibitor of PI3K that exhibits anticancer chemotherapeutic, anti-inflammatory, and anti-arthritis activities. ZSTK474 suppresses expression of matrix metalloproteinases (MMPs), VEGF, and HIF-1α, inhibiting migration, invasion, and adhesive capability of prostate cancer cells. ZSTK474 also induces G1 phase cell cycle arrest without inducing apoptosis in vitro and inhibits tumor growth in vivo. ZSTK474 inhibits the production of prostaglandin E2 (PGE2) in fibroblast-like synovial cells in vitro. In vivo, this compound decreases production of IFN-γ and IL-17, decreases the number of circulating T cells, and inhibits the progression of arthritis.
|
|||||||||||||
Specifications | |||||||||||||
|
上海惠诚生物优势品牌系列:
药物: TRC LGC USP LKT
植提标准品: Extrasynthese PhytoLab Chromadex CaroteNature
糖类: Elicityl TDB Ludger Megazyme Glycarbo
脂类: Nu-Chek Larodan Avanti Matreya
其他: TCI ERM Wako Jackson Cayman laysan Alfa 阿拉丁 麦克林
手机微信:18018625233 QQ:2303607288